Regen Biopharma issues 15K Series NC preferred shares to CEO with super-voting rights

Regen BioPharma Inc

Issued 15,000 Series NC preferred shares to CEO David Koos to settle $10,050 debt.
Each Series NC share carries 334 votes, disproportionately high voting power.
Issuance dilutes common stock voting power and has anti-takeover effect.
Board authorized 20,000 shares of Series NC; 15,000 issued now.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.